Patent ID: 7596836

Claim:
An antiviral solution comprising: a) 15-25% Specially Denatured Alcohol (SDA); b) between about 0.02% and about 4% 4-octylphenol polyethoxylate by volume; c) between about 0.04% to about 0.11% 1,8 cineole by volume; d) between about 0.03% and 0.06% menthol by volume; e) between about 0.02% to about 0.10% thymol by volume; f) between about 0.03% and about 0.08% methyl salicylate by weight; g) sorbitol and/or glycerin to increase the viscosity and add body and texture so that a sufficient amount of solution remains in the nose and throat for 5-20 minutes after application; h) citric acid as a buffering agent for achieving a pH between 3.0 and 5.0; i) and water (q.s. to 100%).